NYSE - Intra-Cellular Therapies, Inc.

График котировок Intra-Cellular Therapies, Inc.


Добавить в список сравнения Добавить в список сравнения
Добавить в список отслеживания Добавить в список отслеживания
Добавить в портфель Добавить в портфель

Основные параметры

P/S 126.38
P/BV 4.41
EV/EBITDA -9.7
EBITDA -0.2307
Цена ао 35.97

Все параметры ⇨

Оценка

Недооценка

Название Значение Оценка
P/S 126.38 1
P/BV 4.41 1
P/E 0
EV/EBITDA -9.7 10

Эффективность

Название Значение Оценка
ROA, % -29.84 1
ROE, % -53.3 1

Дивиденды

Название Значение Оценка
Div yield, % 0
DSI 0 0

Долг

Название Значение Оценка
Долг/EBITDA 0

Импульс роста

Название Значение Оценка
Рост прибыли, % 0 0
Рост цены акции, % 0 0
Рост дивидендов, % 0 0

Основные владельцы

Institutions Объем Доля, %
DCF Advisers, LLC 427000 0.53
Life Sciences Partners 132557 0.17
Bellevue Asset Management AG 3611908 4.51
SSGA Funds Management Inc 548915 0.68
Schroder Investment Management North America Inc. 486509 0.61
First Midwest Bank 8632 0.01
ClearBridge Investments, LLC. 34460 0.04
ClearBridge Investments-LeggMason RETAIL 142 0
Next Edge Capital Corp. 6400 0.01
Legg Mason Partners Fund Advisor, LLC 66550 0.08
Northern Trust Investments Inc 1389000 1.73
Fidelity Management & Research Company LLC 12000487 14.97
BlackRock Fund Advisors 5598441 6.98
ProFund Advisors LLC 10776 0.01
Bellevue Group AG 3579919 4.47
Rhenman Partners Asset Management AB 475000 0.59
Schroders Investment Mgt North America 165382 0.21
Invesco Capital Management LLC 408425 0.51
Hand Benefits & Trust, a BPAS Co 20291 0.03
Guardian 250558 0.31
ClearBridge Investments-Franklin Templeton RETAIL 142 0
Rafferty Asset Management, LLC 17395 0.02
Fidelity Management & Research Company LLC 6996033 8.73
Rhenman & Partners Asset Management AB 475000 0.59
Wagonhound Investments, LP 457720 0.57
Hand Benefits & Trust, a BPAS Co 20291 0.03
ClearBridge Investments, LLC 891000 1.11
CIBC Asset Management Inc 153602 0.19
Delaware Management Company 730000 0.91
Cortina Asset Management LLC 74010 0.09
Nationwide Fund Advisors 92030 0.11
Fidelity SelectCo, LLC 2733109 3.41

Содержится в ETF

ETF Доля, % Доходность за год, % Дивиденды, %
Virtus LifeSci Biotech Products ETF 2.94 29.99 0.79
SPDR S&P Pharmaceuticals ETF 3.42 26.40 0.46

Похожие компании

Описание Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the central nervous system (CNS) in the United States. The company is developing its lead drug candidate, CAPLYTA for the treatment of schizophrenia, bipolar disorder, behavioral disturbances associated with dementia, autism, and other CNS diseases. It is also developing ITI-002 that inhibits the enzyme phosphodiesterase type 1; ITI-214 for Parkinson's disease; and ITI-333, for substance use disorders, pain, and psychiatric comorbidities, including depression and anxiety. Intra-Cellular Therapies, Inc. is headquartered in New York, New York.